Mean ± SD | Women(173) | Men(90) | Overall(263) |
---|---|---|---|
Age (years) | 83.1 ± 7.2 | 82.6 ± 6.9 | 82.9 ± 7.1 |
Weight (kg) | 62.9 ± 11.6 | 73.9 ± 10.1 | 69.8 ± 12.2 |
Height (m) | 1.5 ± 0.1 | 1.6 ± 0.1 | 1.6 ± 0.1 |
BMI (Kg/m2) | 26.4 ± 4.1 | 27.0 ± 3.2 | 26.6 ± 3.9 |
SBP (mm Hg) | 130.6 ± 17.5 | 130.9 ± 17.7 | 130.7 ± 17.5 |
DBP (mm Hg) | 70.8 ± 11.1 | 71.7 ± 11.3 | 71.1 ± 11.2 |
Creatinine (mg/dl) | 1.1 ± 0.9 | 1.30 ± 0.4 | 1.2 ± 0.8 |
Body surface (m2) | 1.6 ± 0.2 | 1.8 ± 0.1 | 1.7 ± 0.2 |
GFR (ml/min/1.73 m2) | 61.0 ± 16.9 | 59.2 ± 16.1 | 60.4 ± 16.7 |
CrCl (ml/min) | 43.0 ± 11.7 | 47.5 ± 12.9 | 45.2 ± 12.2 |
CrCl-BS (ml/min/1.73 m2) | 46.7 ± 11.6 | 44.5 ± 10.9 | 45.0 ± 11.4 |
Total number drugs patient | 7.3 ± 3.0 | 7.2 ± 2.9 | 7.3 ± 2.9 |
Drugs with restrictions per patient | 4.0 ± 1.9 | 4.0 ± 2.9 | 4.0 ± 2.0 |
Number of DRP per patient | 0.7 ± 1.1 | 0.6 ± 1.1 | 0.7 ± 1.1 |
Prevalence of DI (%) | 18.3 ± 28.9 | 15.8 ± 28.4 | 17.5 ± 28.2 |
Population with DRP %(n) | 35.6(32) | 38.2(66) | 37.3(98) |
Comorbidity %(n) | |||
Hypertension | 71.7%(124) | 67.8%(61) | 70.3%(185) |
T2DM | 19.7%(34) | 24.4%(22) | 21.3%(56) |
Dyslipidemia | 37.0%(64) | 36.7%(33) | 36.9%(97) |
Hyper/Hypo Thy | 8.1(14) | 1.1%(1) | 5.7%(15) |
CVD | 26.6(46) | 31.1%(28) | 28.1%(74) |